Ausgabe 10/2021
Inhalt (30 Artikel)
Association between outdoor particulate air pollution and the risk of osteoporosis: a systematic review and meta-analysis
JJ. Liu, SB. Fu, J. Jiang, XL. Tang
How can the orthopedic surgeon ensure optimal vitamin D status in patients operated for an osteoporotic fracture?
T. Chevalley, M.L. Brandi, E. Cavalier, N.C. Harvey, G. Iolascon, C. Cooper, D. Hannouche, J.-F. Kaux, A. Kurth, S. Maggi, G. Maier, K. Papavasiliou, N. Al-Daghri, M. Sosa-Henríquez, N. Suhm, U. Tarantino, J.-Y. Reginster, R. Rizzoli
Burden of disease and clinical targets in adult patients with X-linked hypophosphatemia. A comprehensive review
S. Giannini, M.L. Bianchi, D. Rendina, P. Massoletti, D. Lazzerini, M.L. Brandi
An assessment of intervention thresholds for very high fracture risk applied to the NOGG guidelines
J. A. Kanis, H. Johansson, N. C. Harvey, M. Lorentzon, E. Liu, L. Vandenput, E. V. McCloskey
The treatment gap after major osteoporotic fractures in Denmark 2005-2014: a combined analysis including both prescription-based and hospital-administered anti-osteoporosis medications
M. K. Skjødt, M. T. Ernst, S. Khalid, C. Libanati, C. Cooper, A. Delmestri, K. H. Rubin, M. K. Javaid, D. Martinez-Laguna, E. Toth, D. Prieto-Alhambra, B. Abrahamsen
Impact of population-based or targeted BMD interventions on fracture incidence
N. C. Harvey, J. A. Kanis, E. Liu, L. Vandenput, M. Lorentzon, C. Cooper, E. McCloskey, H. Johansson
Alendronate use in older patients with reduced renal function: challenges and opportunities in clinical practice
N. Naganathar, W. -P. Yau, Z. H. Mok, Z. Y. F. Tan, S. T. H. Chew
Geographical variation in surgical care and mortality following hip fracture in England: a cohort study using the National Hip Fracture Database (NHFD)
A. Shah, S. Hawley, D. S. Inman, C. Cooper, E. Fagan, A. Johansen, A. Judge
Early clinical effects, safety, and predictors of the effects of romosozumab treatment in osteoporosis patients: one-year study
A. Tominaga, K. Wada, K. Okazaki, H. Nishi, Y. Terayama, Y. Kato
Cost effectiveness of romosozumab versus teriparatide for severe postmenopausal osteoporosis in Japan
H. Hagino, K. Tanaka, S. Silverman, M. McClung, S. R. Gandra, M. Charokopou, K. Adachi, B. Johnson, B. Stollenwerk
Efficiently stratifying mid-term death risk in femoral fractures in the elderly: introducing the ASAgeCoGeCC Score
C. Trevisan, G. Gallinari, A. Carbone, R. Klumpp
Higher latitude and lower solar radiation influence on hip fracture admissions in Chilean older population
J. C. R. Ormeño Illanes, I. Quevedo Langenegger
Height loss in postmenopausal women—do we need more for fracture risk assessment? Results from the GO Study
W. Pluskiewicz, P. Adamczyk, B. Drozdzowska
High prevalence of vertebral fractures in seizure patients with normal bone density receiving chronic anti-epileptic drugs
P.M. Dussault, D. McCarthy, S.A. Davis, M. Thakore-James, A.A. Lazzari
Health care utilization and excess costs after pelvic fractures among older people in Germany
S. Andrich, B. Haastert, E. Neuhaus, K. Frommholz, W. Arend, C. Ohmann, J. Grebe, A. Vogt, C. Brunoni, P. Jungbluth, S. Thelen, C.-M. Dintsios, J. Windolf, A. Icks
Development and validation of the risk engine for an Australian Health Economics Model of Osteoporosis
L. Si, J. A. Eisman, T. Winzenberg, K. M. Sanders, J. R. Center, T. V. Nguyen, T. Tran, A. J. Palmer
Physical capability, physical activity, and their association with femoral bone mineral density in adults aged 40 years and older: The Tromsø study 2015–2016
A.V. Hauger, K. Holvik, A. Bergland, A. Ståhle, N. Emaus, B. Morseth, B.H. Strand
Risk factors for multi-joint disease in patients with glucocorticoid-induced osteonecrosis
A. Krez, J. Lane, A. Heilbronner, K.-H. Park-Min, K. Kaneko, T. Pannellini, D. Mintz, D. Hansen, D.J. McMahon, K.A. Kirou, G. Roboz, P. Desai, R.S. Bockman, E.M. Stein
Long-term evaluation of anabolic and anti-resorptive agents in adults with familial osteoporosis due to pro205ala variant of the col1a1 gene
H.K. Datta, J. Vila, S.P. Tuck
Asymptomatic elevated parathyroid hormone level due to immunoassay interference
M.B. Zanchetta, E. Giacoia, F. Jerkovich, E. Fradinger
Subtrochanteric atypical femoral fracture induced solely by glucocorticoid without bisphosphonate treatment: a case report
J.-T. Kim, Y.-H. Cha, S. Jeong, J.-I. Yoo, C.H. Park
Progression of atypical femur stress fracture after discontinuation of bisphosphonate therapy
K.D. Gu, B. Ettinger, C.D. Grimsrud, J.C. Lo
A cautionary case: osteoporotic femur fracture after robotic-assisted total knee arthroplasty
H. E. Skibicki, D. Y. Ponzio, J. A. Brustein, Z. D. Post, A. C. Ong, F. R. Orozco
Denosumab is not associated with risk of malignancy: systematic review and meta-analysis of randomized controlled trials
D. Rosenberg, T. Avni, G. Tsvetov, A. Gafter-Gvili, T. Diker-Cohen
Denosumab is not associated with risk of malignancy? More evidence is needed
J. Zhao, H. Qiu, Y. Lin
Clarification of some issues using Bayesian methods and model selection in meta-analysis and reporting
Q. Wu, H. Mun, B. Liu
Response to: “Zoledronate-induced acute anterior uveitis: a three-case report and brief review of literature”
Priya Samalia, Rachael Niederer
Correction to: The efficacy and safety of menatetrenone in the management of osteoporosis: a systematic review and meta-analysis of randomized controlled trials
S. Su, N. He, P. Men, C. Song, S. Zhai
Correction to: A randomized, controlled trial of once-weekly teriparatide injection versus alendronate in patients at high risk of osteoporotic fracture: primary results of the Japanese osteoporosis intervention Trial-05
H. Hagino, T. Sugimoto, S. Tanaka, K. Sasaki, T. Sone, T. Nakamura, S. Soen, S. Mori